Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Notes Payables (2020 - 2021)

Evolus' Notes Payables history spans 2 years, with the latest figure at $20.0 million for Q3 2021.

  • For Q3 2021, Notes Payables changed N/A year-over-year to $20.0 million; the TTM value through Sep 2021 reached $20.0 million, changed N/A, while the annual FY2020 figure was $19.1 million, N/A changed from the prior year.
  • Notes Payables reached $20.0 million in Q3 2021 per EOLS's latest filing, up from $19.6 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $20.0 million in Q3 2021 to a low of $19.1 million in Q4 2020.